IDDI Lunch & Learn in Durham, NC
Publié le
SAILING SMOOTH SEAS: CHARTING THE COURSE THROUGH NEEDED ADVANCEMENTS IN SAFETY REPORTING AND NEW FDA GUIDANCE ON IDMCs IDDI and…
Lunch & Learn in South San Francisco, CA
Publié le
REGULATORY AND DESIGN TRENDS IN CLINICAL TRIALS IDDI and OWL Oncology Research are pleased to invite you to an exceptional…
Why do so many phase 3 trials fail?
Publié le
Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement…
Best Practices to Accelerate Your Database Lock
Publié le
Accelerating database lock in clinical research is a critical aspect of ensuring timely study conclusions and decision-making. Database lock…
The Key to Successful Regulatory Submission: Ensuring 100% SDTM Compliance in Your SAS Database
Publié le
In the complex and highly regulated world of clinical trials, the submission of data to regulatory authorities is a critical…
Accelerated approvals (AA): not so fast!
Publié le
Everardo D. Saad, MD, Medical Director and Consultant, IDDI Marc Buyse, ScD, Chief Scientific Officer and Consultant, IDDI The development…
How to Optimize Rare Disease Trials
Publié le
Founded in 1991, the International Drug Development Institute (IDDI) is an expert center of biostatistical and integrated e-clinical services…
Generalized Pairwise Comparisons to Assess Treatment Effects
Publié le
JACC Review Topic of the Week We are proud to share the most recent JACC “Review Topic of the Week” featured by the Journal of…
IDDI Exhibitor and Speaker at COG EUROPE
Publié le
Meet IDDI’s experts at COG EUROPE – Booth #29 IDDI’s team would be glad to discuss how we can help…
IDDI at BeCRO Battle 2023
Publié le
IDDI Sponsor at the BeCRO Battle 2023 – ‘The Return’. This year the event will focus on Belgian competitiveness in…